Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings Call Transcript

Operator Good morning and thank you for standing by. Welcome to Abbott's First Quarter 2023 Earnings Conference Call.

Related Keywords

United States ,Brazil ,China ,Japan ,America ,Bob Funck ,Robert Ford ,Larry Biegelsen ,Scott Leinenweber ,Core Lab ,Wells Fargo ,Abbott Laboratories ,Core Laboratory Diagnostics ,Call Transcript April ,First Quarter ,Vice President ,Investor Relations ,Acquisitions Scott Leinenweber Good ,Chief Executive Officer ,Executive Vice President ,Chief Financial ,Private Securities Litigation Reform Act ,Risk Factors ,Robert Ford Thanks ,Medical Devices ,Established Pharmaceuticals ,Highest Acceptance Rates ,Southeast Asia ,Care Diagnostics In Core Lab ,Diabetes Care ,Freestyle Libre ,Cardiovascular Devices ,Cardiovascular Device ,Heart Failure ,Structural Heart In Failure ,Structural Heart ,Bob Funck Thanks ,January Regarding ,Question And Answer Session Operator Thank ,Performing European Stocks So Far ,Healthcare Stocks ,Larry Biegelsen Good ,Robert Ford Sure ,Larry Biegelsen That ,